OFEV® (nintedanib) time to face IPF head on A common threat of Pulmonary fibrosis Document ID: PC-ZA-102060 04/05/2023 Author: Boehringer Ingelheim Broad range of patients RELATED CONTENT PC-ZA-102060 Production date: May 2023
